Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial
托瑞普利单抗联合化疗一线治疗晚期非小细胞肺癌（CHOICE-01）：一项随机、双盲、3期试验的最终总生存期和生物标志物探索
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-024-02087-6
Zhong, Jia; Fei, Kailun; Wu, Lin; Li, Baolan; Wang, Zhijie; Cheng, Ying; Li, Xiaoling; Wang, Xicheng; Han, Liang; Wu, Xiaohong; Fan, Yun; Yu, Yan; Lv, Dongqing; Shi, Jianhua; Huang, Jianjin; Zhou, Shaozhang; Han, Baohui; Sun, Guogui; Guo, Qisen; Ji, Youxin; Zhu, Xiaoli; Hu, Sheng; Zhang, Wei; Wang, Qiming; Jia, Yuming; Wang, Ziping; Song, Yong; Wu, Jingxun; Shi, Meiqi; Li, Xingya; Han, Zhigang; Liu, Yunpeng; Yu, Zhuang; Liu, An-Wen; Wang, Xiuwen; Zhou, Caicun; Zhong, Diansheng; Miao, Liyun; Zhang, Zhihong; Zhao, Hui; Yang, Jun; Wang, Dong; Wang, Yingyi; Li, Qiang; Zhang, Xiaodong; Ji, Mei; Yang, Zhenzhou; Cui, Jiuwei; Gao, Beili; Wang, Buhai; Liu, Hu; Nie, Lei; He, Mei; Jin, Shi; Gu, Wei; Shu, Yongqian; Zhou, Tong; Feng, Jian; Yang, Xinmei; Huang, Cheng; Zhu, Bo; Yao, Yu; Yao, Sheng; Yu, Jianjun; Cai, Shang Li; Cai, Yiran; Xu, Jiachen; Zhuang, Wei; Luo, Xianmin; Duan, Jianchun; Wang, Jie
